Early Investors: Holographic "Phones" Are Coming...
Is that coffee machine real or digital?

To potentially profit, click before Oct. 27th.
Learn more.
pixel

AUP Insider Trading (Aurinia Pharmaceuticals)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$449,335.92
Insider Selling (Last 12 Months): C$2,012,995.00

Aurinia Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Aurinia Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aurinia Pharmaceuticals Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 07/30/2021 01:00 AM ET

This chart shows the closing price history over time for AUP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarketBeat's Top 5 Stock Picks - Just Released
MarketBeat has just released five new trading ideas, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys.
View the Stocks Here

Aurinia Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/21/2021Robert HuizingaSenior OfficerBuy16,000C$3.47C$55,545.60122,092
9/20/2021Michael Robert MartinDirectorBuy28,500C$7.00C$199,386.00171,324
9/13/2021Michael Robert MartinDirectorBuy25,000C$7.01C$175,230.00167,824
9/10/2021Robert HuizingaSenior OfficerSell32,500C$27.92C$907,335.00106,092
9/7/2021Michael Robert MartinDirectorSell7,500C$23.89C$179,190.00142,824
9/7/2021Robert HuizingaSenior OfficerSell5,000C$24.16C$120,780.00138,592
8/26/2021Michael Robert MartinDirectorSell22,500C$23.51C$528,957.00150,324
8/25/2021Neil SolomonsSenior OfficerSell5,000C$20.92C$104,610.00137,299
7/28/2021Michael Robert MartinDirectorSell5,000C$17.41C$87,073.00177,824
6/22/2021Michael Robert MartinDirectorSell5,000C$17.01C$85,050.00182,824
1/28/2021Stephen P. RobertsonSenior OfficerBuy900C$21.30C$19,174.322,720
9/21/2020Chin Kyu HuhInsiderSell48,458C$19.91C$964,988.546,499,881
8/18/2020Robert HuizingaSenior OfficerSell14,000C$19.01C$266,176.40103,592
7/8/2020Neil SolomonsSenior OfficerSell10,000C$21.15C$211,500.00187,299
4/9/2020Neil SolomonsSenior OfficerSell4,100C$21.04C$86,279.17197,299
4/6/2020Neil SolomonsSenior OfficerSell15,000C$21.11C$316,617.00202,299
1/2/2020Dennis BourgeaultSenior OfficerSell3,000C$27.62C$82,860.0070,891
12/16/2019Dennis BourgeaultSenior OfficerSell5,000C$24.08C$120,400.0073,891
12/12/2019Dennis BourgeaultSenior OfficerSell5,000C$24.55C$122,750.0016,452
10/15/2019Joseph Patrick HaganDirectorBuy2,000C$6.28C$12,553.203,500
10/14/2019Bradley DickersonSenior OfficerBuy5,000C$5.11C$25,542.0015,000
10/11/2019Joseph Patrick HaganDirectorBuy1,500C$5.11C$7,660.031,500
9/26/2019Stephen P. RobertsonSenior OfficerBuy1,050C$7.44C$7,812.001,820
7/1/2019Bradley DickersonSenior OfficerBuy2,000C$8.71C$17,424.007,000
4/25/2019Neil SolomonsSenior OfficerSell34,733C$8.44C$293,285.45253,266
4/23/2019Neil SolomonsSenior OfficerSell10,000C$8.53C$85,279.00287,999
See Full Table
Insider Trading at Aurinia Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aurinia Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Aurinia Pharmaceuticals (TSE:AUP)

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Read More on Aurinia Pharmaceuticals

Today's Range

Now: N/A

50 Day Range

MA: C$15.92
Low: C$13.72
High: C$17.84

52 Week Range

Now: N/A

Volume

4,611,683 shs

Average Volume

229,895 shs

Market Capitalization

C$2.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals' top insider shareholders include:
  1. Chin Kyu Huh (Insider)
  2. Neil Solomons (Senior Officer)
  3. Michael Robert Martin (Director)
  4. Robert Huizinga (Senior Officer)
  5. Dennis Bourgeault (Senior Officer)
  6. Bradley Dickerson (Senior Officer)
  7. Joseph Patrick Hagan (Director)
  8. Stephen P Robertson (Senior Officer)
Overnight Trade Opportunity Next Week?!
I'm looking at a BIG Overnight Trade opportunity next week...It's so big...

I'm going to give it to you FREE!

In fact, for the week of October 4-8, you can join our FREE Open House!

You can get ALL our Overnight Trade recommendations, plus ALL of our research and real-time recommendations!
Go Here to Join.
pixel